3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
114
Stomach Neoplasms
19
HER2-positive Breast Cancer
14
Neoplasms
12
Neoplasm Metastasis
12
Colorectal Neoplasms
11
Esophageal Neoplasms
9
Triple Negative Breast Neoplasms
5
Lung Neoplasms
5
Colonic Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Brain Neoplasms
5
Rectal Neoplasms
4
Ovarian Neoplasms
4
Meningeal Neoplasms
4
Endometrial Neoplasms
4
Biliary Tract Neoplasms
4
Adenocarcinoma Of Esophagus
4
Uterine Cervical Neoplasms
3
Salivary Gland Neoplasms
3
Prostatic Neoplasms
3
Pancreatic Neoplasms
3
Multiple Myeloma
3
Meningeal Carcinomatosis
3
Lymphoma, Non-Hodgkin
3
Inflammatory Breast Neoplasms
3
Hematologic Neoplasms
3
Gallbladder Neoplasms
3
Breast Diseases
3
Anatomic Stage I Breast Cancer AJCC v8
3
Interventions
pembrolizumab
2
atezolizumab
2
Paclitaxel
2
Carboplatin
2
veliparib
1
sintilimab
1
pertuzumab
1
pemigatinib
1
olaparib
1
ivosidenib
1
ipatasertib
1
entrectinib
1
cobimetinib
1
alectinib
1
Whole Genome Sequencing
1
Vemurafenib
1
Transurethral Resection of Prostate
1
Taxes
1
Surveys and Questionnaires
1
Specimen Handling
1
Sequence Analysis, RNA
1
Radiosurgery
1
Magnetic Resonance Spectroscopy
1
HhAntag691
1
Genetic Testing
1
Gemcitabine
1
Fluorodeoxyglucose F18
1
FAPI-46
1
Erlotinib Hydrochloride
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms, Unknown Primary
×
Trastuzumab
×
1 year
×
Clear all
No trials found.